Key result
In a patient with CPVT triggered by blunt chest trauma, treatment with an implantable cardioverter defibrillator, beta-blockers, and flecainide successfully prevented recurrent ICD shocks.
Case Report (n=1)
In a patient with CPVT presenting with cardiac arrest after blunt chest trauma, the addition of flecainide to ICD and beta-blocker therapy successfully prevented recurrent ICD shocks.
May support flecainide addition in trauma-triggered CPVT; hypothesis-generating and requires prospective validation.
UNLABELLED: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an electrophysiological disorder of a physically normal heart that occurs in children when the body is subjected to intense emotional or physical stress that causes adrenergic discharge. This troubling disease can be sporadic (spontaneous) or familial (genetic/inherited). Unfortunately, its associated ventricular tachycardia may cause sudden death, so early diagnosis of CPVT is very important. Treatment modalities include medical treatment, implantation of a cardioverter defibrillator, or surgical sympatectomy; but the implantable cardioverter defibrillator (ICD) should be the first choice in patients with a history of cardiac arrest. We herein present the case of a patient diagnosed with CPVT after a successful cardiopulmonary resuscitation triggered by blunt chest trauma. We implanted an implantable cardioverter defibrillator and started oral B-blocker treatment. During the course of follow-up, flecainide was added to his treatment depending on the patient's status regarding recurrent ICD shock. The patient has now continued follow-up without recurrent ICD shock since flecainide treatment was initiated. In conclusion, in patients with syncope and sudden cardiac arrest secondary to physical stress or blunt chest trauma, CPVT should be considered and an implantable cardioverter defibrillator must be implanted. Additionally, flecainide theraphy should be considered to decrease recurrent ICD shock.
No takes yet. Share an insight, caveat, or question.
Özyılmaz et al. (2015) conducted a case report in Catecholaminergic polymorphic ventricular tachycardia (CPVT) (n=1). Implantable cardioverter defibrillator (ICD), beta-blocker, and flecainide was evaluated on Recurrent ICD shock. In a patient with CPVT triggered by blunt chest trauma, treatment with an implantable cardioverter defibrillator, beta-blockers, and flecainide successfully prevented recurrent ICD shocks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: